FIGURE 11.2 Insulin-induced ROS production and PTP regulation via Nox4 in insulinsensitive cells. This figure illustrates the action of insulin to stimulate receptor tyrosine autophosphorylation which activates the receptor toward its cellular substrate (IRS) proteins. The receptor and IRS tyrosine phosphorylation require cellular PTP activity to return to a basal state. The insulin receptor is coupled to the Nox4 homolog of NADPH oxidase and stimulates the cellular generation of reactive oxygen species which, in turn, leads to oxidative inhibition of the thiol-dependent PTPs, including PTP1B, the major phosphatase for the insulin signaling cascade. The lower right portion illustrates the PTP reaction mechanism in which the reduced thiol side chain in the enzyme catalytic domain forms a phosphocysteine intermediate with the phosphotyrosine substrate. If the catalytic PTP thiol is oxidized, this reaction intermediate cannot form and the enzymatic reaction is blocked. See text for discussion and references.

homologs catalyzes the generation of ROS at the plasma membrane, we have recently provided evidence in the 3T3-L1 adipocyte system that Nox4, which is expressed in insulin-sensitive cell types, is a novel molecular target that may mediate this process (Figure 11.2).


This work was supported by National Institutes of Health grant RO1 DK43396 to Dr. Goldstein.


1. Evans, J.L. et al. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr. Rev. 23, 599, 2002.

2. Ceriello, A. and Motz, E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler. Thromb. Vasc. Biol. 24, 816, 2004.

3. Houstis, N., Rosen, E.D., and Lander, E.S. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 440, 944, 2006.

Mahadev, K. et al. The NAD(P)H oxidase homolog Nox4 modulates insulin-stimulated generation of H2O2 and plays an integral role in insulin signal transduction. Mol. Cell. Biol. 24, 1844, 2004.

Goldstein, B.J., Mahadev, K., and Wu, X. Redox paradox: insulin action is facilitated by insulin-stimulated reactive oxygen species with multiple potential signaling targets. Diabetes 54, 311, 2005.

Goldstein, B.J. et al. Role of insulin-induced reactive oxygen species in the insulin signaling pathway. Antioxid. Redox Signal. 7, 1021, 2005.

Goldstein, B.J. Insulin resistance as the core defect in type 2 diabetes mellitus. Am. J. Cardiol. 90, 3, 2002.

Stumvoll, M., Goldstein, B.J., and van Haeften, T.W. Type 2 diabetes: principles of pathogenesis and therapy. Lancet 365, 1333, 2005.

Kido, Y., Nakae, J., and Accili, D. The insulin receptor and its cellular targets. J. Clin. Endocr. Metab. 86, 972, 2001.

White, M.F. IRS proteins and the common path to diabetes. Am. J. Physiol. Endocrinol. Metab. 283, E413, 2002.

Goldstein, B.J. Protein-tyrosine phosphatases and the regulation of insulin action, in Diabetes Mellitus: A Fundamental and Clinical Text, 3rd ed., LeRoith, D. et al., Eds., Lippincott, Philadelphia, 2003, p. 255.

Goldstein, B.J. Protein-tyrosine phosphatase 1B (PTP1B): a novel therapeutic target for type 2 diabetes mellitus, obesity and related states of insulin resistance. Curr. Drug Targets Immune. Endocr. Metabol. Disord. 1, 265, 2001. Asante-Appiah, E. and Kennedy, B.P. Protein tyrosine phosphatases: the quest for negative regulators of insulin action. Am. J. Physiol. Endocrinol. Metab. 284, E663, 2003.

Tonks, N.K. PTP1B: from the sidelines to the front lines! FEBS Lett. 546, 140, 2003.

Elchebly, M., Cheng, A., and Tremblay, M.L. Modulation of insulin signaling by protein tyrosine phosphatases. J. Molec. Med. 78, 473, 2000. Klaman, L.D. et al. Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol. Cell. Biol. 20, 5479, 2000.

Hashimoto, N., Zhang, W.R., and Goldstein, B.J. Insulin receptor and epidermal growth factor receptor dephosphorylation by three major rat liver protein-tyrosine phosphatases expressed in a recombinant bacterial system. Biochem. J. 284, 569, 1992.

Walchli, S. et al. Identification of tyrosine phosphatases that dephosphorylate the insulin receptor: a brute force approach based on "substrate-trapping" mutants. J. Biol. Chem. 275, 9792, 2000.

Goldstein, B.J. et al. Tyrosine dephosphorylation and deactivation of insulin receptor substrate-1 by protein-tyrosine phosphatase 1B: possible facilitation by the formation of a ternary complex with the Grb2 adaptor protein. J. Biol. Chem. 275, 4283, 2000.

Calera, M.R., Vallega, G., and Pilch, P.F. Dynamics of protein-tyrosine phosphatases in rat adipocytes. J. Biol. Chem. 275, 6308, 2000. Puius, Y.A. et al. Identification of a second aryl phosphate-binding site in protein-tyrosine phosphatase 1b: a paradigm for inhibitor design. Proc. Natl. Acad. Sci. USA 94, 13420, 1997.

22. Salmeen, A. et al. Molecular basis for the dephosphorylation of the activation segment of the insulin receptor by protein tyrosine phosphatase 1B. Mol. Cell 6, 1401, 2000.

23. Dadke, S. and Chernoff, J. Interaction of protein tyrosine phosphatase (PTP) 1B with its substrates is influenced by two distinct binding domains. Biochem. J. 364, 377, 2002.

24. Tonks, N.K. and Neel, B.G. Combinatorial control of the specificity of protein tyrosine phosphatases. Curr. Opin. Cell Biol. 13, 182, 2001.

25. Andersen, J.N. et al. Structural and evolutionary relationships among protein tyrosine phosphatase domains. Mol. Cell Biol. 21, 7117, 2001.

26. Keyse, S.M. Protein phosphatases and the regulation of mitogen-activated protein kinase signalling. Curr. Opin. Cell Biol. 12, 186, 2000.

27. Zhang, Z.Y. Protein tyrosine phosphatases: structure and function, substrate specificity, and inhibitor development. Annu. Rev. Pharmacol. Toxicol. 42, 209, 2002.

28. Denu, J.M. and Dixon, J.E. Protein tyrosine phosphatases: mechanisms of catalysis and regulation. Curr. Opin. Chem. Biol. 2, 633, 1998.

29. Zhang, Z.Y. Mechanistic studies on protein tyrosine phosphatases. Progr. Nucl. Acid Res. Mol. Biol. 73, 171, 2003.

30. Mahadev, K. et al. Insulin-stimulated hydrogen peroxide reversibly inhibits pro-tein-tyrosine phosphatase 1B in vivo and enhances the early insulin action cascade. J. Biol. Chem. 276, 21938, 2001.

31. Mahadev, K. et al. Hydrogen peroxide generated during cellular insulin stimulation is integral to activation of the distal insulin signaling cascade in 3T3-L1 adipocytes. J. Biol. Chem. 276, 48662, 2001.

32. Meng, T.C., Fukada, T., and Tonks, N.K. Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol. Cell 9, 387, 2002.

33. Rhee, S.G. et al. Intracellular messenger function of hydrogen peroxide and its regulation by peroxiredoxins. Curr. Opin. Cell Biol. 17, 183, 2005.

34. Sundaresan, M. et al. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 270, 296, 1995.

35. Bae, Y.S. et al. Epidermal growth factor (EGF)-induced generation of hydrogen peroxide: role in EGF receptor-mediated tyrosine phosphorylation. J. Biol. Chem. 272, 217, 1997.

36. Stone, J.R. and Yang, S. Hydrogen peroxide: a signaling messenger. Antioxid. Redox Signal. 8, 243, 2006.

37. Lee, S.R. et al. Reversible inactivation of protein-tyrosine phosphatase 1b in a431 cells stimulated with epidermal growth factor. J. Biol. Chem. 273, 15366, 1998.

38. DeGnore, J.P. et al. Identification of the oxidation states of the active site cysteine in a recombinant protein tyrosine phosphatase by electrospray mass spectrometry using on-line desalting. Rapid Commun. Mass Spectrom. 12, 1457, 1998.

39. Meng, T.C. et al. Regulation of insulin signaling through reversible oxidation of the protein-tyrosine phosphatases TC45 and PTP1B. J. Biol. Chem. 279, 37716, 2004.

40. Denu, J.M. and Tanner, K.G. Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation. Biochemistry 37, 5633, 1998.

41. Barrett, W.C. et al. Roles of superoxide radical anion in signal transduction mediated by reversible regulation of protein-tyrosine phosphatase 1B. J. Biol. Chem. 274, 34543, 1999.

Rhee, S.G. et al. Cellular regulation by hydrogen peroxide. J. Am. Soc. Nephrol. 14, S211, 2003.

Claiborne, A. et al. Protein sulfenic acids: diverse roles for an unlikely player in enzyme catalysis and redox regulation. Biochemistry 38, 15407, 1999. Claiborne, A. et al. Protein sulfenic acid stabilization and function in enzyme catalysis and gene regulation. FASEB J. 7, 1483, 1993.

Skorey, K. et al. How does alendronate inhibit protein-tyrosine phosphatases. J. Biol. Chem. 272, 22472, 1997.

Barrett, W.C. et al. Regulation of PTP1B via glutathionylation of the active site cysteine 215. Biochemistry 38, 6699, 1999.

van Montfort, R.L. et al. Oxidation state of the active-site cysteine in protein tyrosine phosphatase 1B. Nature 423, 773, 2003.

Salmeen, A. et al. Redox regulation of protein tyrosine phosphatase 1B involves a sulphenyl-amide intermediate. Nature 423, 769, 2003.

Czech, M.P. and Fain, J.N. Cu++-dependent thiol stimulation of glucose metabolism in white fat cells. J. Biol. Chem. 247, 6218, 1972.

Czech, M.P., Lawrence, J.C., Jr., and Lynn, W.S. Evidence for electron transfer reactions involved in the Cu2+-dependent thiol activation of fat cell glucose utilization. J. Biol. Chem. 249, 1001, 1974.

May, J.M. The insulin-like effects of low molecular weight thiols: role of trace metal contamination of commercial thiols. Horm. Metab Res. 12, 587, 1980. Livingston, J.N., Gurny, P.A., and Lockwood, D.H. Insulin-like effects of polyamines in fat cells: mediation by H2O2 formation. J. Biol. Chem. 252, 560, 1977.

May, J.M. and de Haen, C. The insulin-like effect of hydrogen peroxide on pathways of lipid synthesis in rat adipocytes. J. Biol. Chem. 254, 9017, 1979. May, J.M. and de Haen, C. Insulin-stimulated intracellular hydrogen peroxide production in rat epididymal fat cells. J. Biol. Chem. 254, 2214, 1979. Mukherjee, S.P. and Lynn, W.S. Reduced nicotinamide adenine dinucleotide phosphate oxidase in adipocyte plasma membrane and its activation by insulin: possible role in the hormone's effects on adenylate cyclase and the hexose monophosphate shunt. Arch. Biochem. Biophys. 184, 69, 1977.

Mukherjee, S.P., Lane, R.H., and Lynn, W.S. Endogenous hydrogen peroxide and peroxidative metabolism in adipocytes in response to insulin and sulfhydryl reagents. Biochem. Pharmacol. 27, 2589, 1978.

Krieger-Brauer, H.I. and Kather, H. Human fat cells possess a plasma membrane-bound H2O2-generating system that is activated by insulin via a mechanism bypassing the receptor kinase. J. Clin Invest. 89, 1006, 1992. Krieger-Brauer, H.I. and Kather, H. The stimulus-sensitive H2O2-generating system present in human fat-cell plasma membranes is multireceptor-linked and under antagonistic control by hormones and cytokines. Biochem. J. 307, 543, 1995. Krieger-Brauer, H.I. and Kather, H. Antagonistic effects of different members of the fibroblast and platelet-derived growth factor families on adipose conversion and NADPH-dependent H2O2 generation in 3T3 L1-cells. Biochem. J. 307, 549, 1995.

Zhu, L. et al. Use of an anaerobic environment to preserve the endogenous activity of protein-tyrosine phosphatases isolated from intact cells. FASEB J. 15, 1637, 2001.

61. McClung, J.P. et al. Development of insulin resistance and obesity in mice over-expressing cellular glutathione peroxidase. Proc. Natl. Acad. Sci. USA 101, 8852, 2004.

62. Hwang, J.J. and Hur, K.C. Insulin cannot activate extracellular-signal-related kinase due to inability to generate reactive oxygen species in SK-N-BE(2) human neuroblastoma cells. Mol. Cell 20, 280, 2005.

63. Brownlee, M. Biochemistry and molecular cell biology of diabetic complications. Nature 414, 813, 2001.

64. Go, Y.M. et al. H2O2-dependent activation of GCLC-ARE4 reporter occurs by mitogen-activated protein kinase pathways without oxidation of cellular glu-tathione or thioredoxin-1. J. Biol. Chem. 279, 5837, 2004.

65. Dooley, C.T. et al. Imaging dynamic redox changes in mammalian cells with green fluorescent protein indicators. J. Biol. Chem. 279, 22284, 2004.

66. Saltiel, A.R. and Pessin, J.E. Insulin signaling in microdomains of the plasma membrane. Traffic 4, 711, 2003.

67. Reynolds, A.R. et al. EGFR activation coupled to inhibition of tyrosine phosphatases causes lateral signal propagation. Nat. Cell. Biol. 5, 447, 2003.

68. Mahadev, K. et al. Integration of multiple downstream signals determines the net effect of insulin on MAP kinase vs. PI 3-kinase activation: potential role of insulin-stimulated H2O2. Cell Signal. 16, 323, 2004.

69. Lambeth, J.D. NOX enzymes and the biology of reactive oxygen. Nat. Rev. Immunol. 4, 181, 2004.

70. Geiszt, M. et al. Identification of renox, an NAD(P)H oxidase in kidney. Proc. Natl. Acad. Sci. USA 97, 8010, 2000.

71. Cheng, G. et al. Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5. Gene 269, 131, 2001.

72. Shiose, A. et al. A novel superoxide-producing NAD(P)H oxidase in kidney. J. Biol. Chem. 276, 1417, 2001.

73. Hordijk, P.L. Regulation of NADPH oxidases: role of Rac proteins. Circ. Res. 98, 453, 2006.

74. Ambasta, R.K., et al., Direct interaction of the novel Nox proteins with p22phox is required for the formation of a functionally active NADPH oxidase. J. Biol. Chem. 279, 45935, 2004.

75. Babior, B.M., Lambeth, J.D., and Nauseef, W. The neutrophil NADPH oxidase. Arch. Biochem. Biophys. 397, 342, 2002.

76. Banfi, B. et al. Two novel proteins activate superoxide generation by the NADPH oxidase NOX1. J. Biol. Chem. 278, 3510, 2003.

77. Takeya, R. et al. Novel human homologues of p47phox and p67phox participate in activation of superoxide-producing NADPH oxidases. J. Biol. Chem. 278, 25234, 2003.

78. Geiszt, M. et al. Proteins homologous to p47phox and p67phox support superoxide production by NAD(P)H oxidase 1 in colon epithelial cells. J. Biol. Chem. 278, 20006, 2003.

79. Cheng, G. and Lambeth, J.D. NOXO1, regulation of lipid binding, localization, and activation of Nox1 by the Phox homology (PX) domain. J. Biol. Chem. 279, 4737, 2004.

80. Cheng, G., Ritsick, D., and Lambeth, J.D. Nox3 regulation by NOXO1, p47phox, and p67phox. J. Biol. Chem. 279, 34250, 2004.

Banfi, B. et al. NOX3: a superoxide-generating NADPH oxidase of the inner ear. J. Biol. Chem. 279, 46065, 2004.

Cheng, G. and Lambeth, J.D. Alternative mRNA splice forms of NOXO1: differential tissue expression and regulation of Noxl and Nox3. Gene 356, 118, 2005. Cheng, G. et al. Nox1-dependent reactive oxygen generation is regulated by Rac1. J. Biol. Chem. epub M512751200, 2006.

Banfi, B. et al. Mechanism of Ca2+ activation of the NADPH oxidase 5 (NOX5). J. Biol. Chem. 279, 18583, 2004.

Lassegue, B. and Clempus, R.E. Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am. J. Physiol. Regul. Integr. Comp Physiol. 285, R277, 2003.

Sundaresan, M. et al. Regulation of reactive-oxygen-species generation in fibroblasts by Rac1. Biochem. J. 318 (Pt. 2), 379, 1996.

Gorin, Y. et al. Nox4 mediates angiotensin II-induced activation of Akt/protein kinase B in mesangial cells. Am. J. Physiol. Renal Physiol. 285, F219, 2003. JeBailey, L. et al. Skeletal muscle cells and adipocytes differ in their reliance on TC10 and Rac for insulin-induced actin remodeling. Mol. Endocrinol. 18, 359, 2004.

Waters, C., Pyne, S., and Pyne, N.J. The role of G-protein coupled receptors and associated proteins in receptor tyrosine kinase signal transduction. Semin. Cell Dev. Biol. 15, 309, 2004.

Malbon, C.C. Insulin signalling: putting the 'G-' in protein-protein interactions. Biochem. J. 380, e11, 2004.

Krieger-Brauer, H.I., Medda, P.K., and Kather, H. Insulin-induced activation of NADPH-dependent H2O2 generation in human adipocyte plasma membranes is mediated by Galphai2. J. Biol. Chem. 272, 10135, 1997.

Kreuzer, J., Nurnberg, B., and Krieger-Brauer, H.I. Ligand-dependent auto-phos-phorylation of the insulin receptor is positively regulated by Gi-proteins. Biochem. J. 380, 831, 2004.

Muller-Wieland, D. et al. Pertussis toxin inhibits autophosphorylation and activation of the insulin receptor kinase. Biochem. Biophys. Res. Commun. 181, 1479, 1991.

Ferreira, I.A. et al. IRS-1 mediates inhibition of Ca2+ mobilization by insulin via the inhibitory G-protein Gi. J. Biol. Chem. 279, 3254, 2004. Moxham, C.M. and Malbon, C.C. Insulin action impaired by deficiency of the G-protein subunit Gi-alpha-2. Nature 379, 840, 1996.

Chen, J.F. et al. Conditional, tissue-specific expression of Q205L G alpha i2 in vivo mimics insulin action. J. Mol. Med. 75, 283, 1997.

Zheng, X.L. et al. Expression of constitutively activated Gi-alpha-2 in vivo ameliorates streptozotocin-induced diabetes. J. Biol. Chem. 273 , 23649, 1998. Song, X. et al. G-alpha-i2 enhances in vivo activation of and insulin signaling to GLUT4. J. Biol. Chem. 276, 34651, 2001.

Guy, G.R. et al. Inactivation of a redox-sensitive protein phosphatase during the early events of tumor necrosis factor/interleukin-1 signal transduction. J. Biol. Chem. 268, 2141, 1993.

Kusari, A.B. et al. Insulin-induced mitogen-activated protein (MAP) kinase phos-phatase-1 (MKP-1) attenuates insulin-stimulated MAP kinase activity: a mechanism for the feedback inhibition of insulin signaling. Mol. Endocrinol. 11, 1532, 1997.

101. Nakashima, N. et al. The tumor suppressor PTEN negatively regulates insulin signaling in 3T3-L1 adipocytes. J. Biol. Chem. 275, 12889, 2000.

102. Lee, S.R. et al. Reversible inactivation of the tumor suppressor PTEN by H2O2. J. Biol. Chem. 277, 20336, 2002.

103. Leslie, N.R. et al. Redox regulation of PI 3-kinase signalling via inactivation of PTEN. EMBO J. 22, 5501, 2003.

104. Wu, Y., Kwon, K.S., and Rhee, S.G. Probing cellular protein targets of H2O2 with fluorescein-conjugated iodoacetamide and antibodies to fluorescein. FEBS Lett. 440, 111, 1998.

105. Kim, J.R. et al. Identification of proteins containing cysteine residues that are sensitive to oxidation by hydrogen peroxide at neutral pH. Anal. Biochem. 283, 214, 2000.

106. Finkel, T. Oxidant signals and oxidative stress. Curr. Opin. Cell Biol. 15, 247, 2003.

12 Intracellular Signaling Pathways and Peroxisome Proliferator-Activated Receptors in Vascular Health in Hypertension and in Diabetes

Diabetes 2

Diabetes 2

Diabetes is a disease that affects the way your body uses food. Normally, your body converts sugars, starches and other foods into a form of sugar called glucose. Your body uses glucose for fuel. The cells receive the glucose through the bloodstream. They then use insulin a hormone made by the pancreas to absorb the glucose, convert it into energy, and either use it or store it for later use. Learn more...

Get My Free Ebook

Post a comment